ConductScience.org, home

Paper39340593

Therapeutic applications and challenges in myostatin inhibition for enhanced skeletal muscle mass and functions.

Wetzlich B and 2 others. Mol Cell Biochem, 2025. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. Therapeutic applications and challenges in myostatin inhibition for enhanced skeletal muscle mass and functions. Papers, record 39340593. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39340593

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapeutic applications and challenges in myostatin inhibition for enhanced skeletal muscle mass and functions.
PubMed
Journal
Mol Cell Biochem
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
17.71, provisional
iCite
Revised in PubMed
2025-05-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wetzlich BBrock
2Nyakundi BBBenard B
3Yang JJinzeng

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MyostatinMajor topic
Muscle, SkeletalMajor topic
Muscular DystrophiesMajor topic
Humans
Animals

References152

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111459935Regulation of myostatin activity and muscle growth.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11459935PubMed
230380014
Relationship of Circulating Growth and Differentiation Factors 8 and 11 and Their Antagonists as Measured Using Liquid Chromatography-Tandem Mass Spectrometry With Age and Skeletal Muscle Strength in Healthy Adults.
J Gerontol A Biol Sci Med Sci2019https://conductscience.org/library/papers/30380014PubMed
329396542Blocking extracellular activation of myostatin as a strategy for treating muscle wasting.Sci Rep2018https://conductscience.org/library/papers/29396542PubMed
432997846Molecular basis and therapeutic potential of myostatin on bone formation and metabolism in orthopedic disease.Biofactors2023https://conductscience.org/library/papers/32997846PubMed
525322757A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy.Mol Ther2015https://conductscience.org/library/papers/25322757PubMed
633597289Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT.Neurology2021https://conductscience.org/library/papers/33597289PubMed
726858428Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice.Proc Natl Acad Sci U S A2016https://conductscience.org/library/papers/26858428PubMed
824333131A myostatin and activin decoy receptor enhances bone formation in mice.Bone2014https://conductscience.org/library/papers/24333131PubMed
920877574Myostatin expression, lymphocyte population, and potential cytokine production correlate with predisposition to high-fat diet induced obesity in mice.PLoS One2010https://conductscience.org/library/papers/20877574PubMed
109139826Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member.Nature1997https://conductscience.org/library/papers/9139826PubMed
119288100A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle.Nat Genet1997https://conductscience.org/library/papers/9288100PubMed
1221508334Human myostatin negatively regulates human myoblast growth and differentiation.Am J Physiol Cell Physiol2011https://conductscience.org/library/papers/21508334PubMed
1320810712Regulation of muscle mass by follistatin and activins.Mol Endocrinol2010https://conductscience.org/library/papers/20810712PubMed
1419549734Excessive loss of skeletal muscle mass in older adults with type 2 diabetes.Diabetes Care2009https://conductscience.org/library/papers/19549734PubMed
1521427410Increased energy expenditure and leptin sensitivity account for low fat mass in myostatin-deficient mice.Am J Physiol Endocrinol Metab2011https://conductscience.org/library/papers/21427410PubMed
167885475Multiple defects and perinatal death in mice deficient in follistatin.Nature1995https://conductscience.org/library/papers/7885475PubMed
1717689926Regulation of myostatin signaling by c-Jun N-terminal kinase in C2C12 cells.Cell Signal2007https://conductscience.org/library/papers/17689926PubMed
1812447939Loss of myostatin attenuates severity of muscular dystrophy in mdx mice.Ann Neurol2002https://conductscience.org/library/papers/12447939PubMed
1922340904The central role of myostatin in skeletal muscle and whole body homeostasis.Acta Physiol (Oxf)2012https://conductscience.org/library/papers/22340904PubMed
2019356623Measurement of myostatin concentrations in human serum: Circulating concentrations in young and older men and effects of testosterone administration.Mol Cell Endocrinol2009https://conductscience.org/library/papers/19356623PubMed

See all 152 referencesDownload CSV of references

Cited by47

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
42939781Skeletal Muscle Aging Is a Significant Contributor to Systemic Aging.Biomolecules2026https://conductscience.org/library/papers/42939781PubMed
42929882Disruption of the Muscle-Brain Axis in Ageing: Role of Myokines in Sarcopenia and Neurodegeneration.Cells2026https://conductscience.org/library/papers/42929882PubMed
42929233Myostatin/Smad3 in Spinal Muscular Atrophy: Biomarkers of Disease Severity and Treatment Response.Ann Clin Transl Neurol2026https://conductscience.org/library/papers/42929233PubMed
42828647MuSC cultivation for cultured meat production: recent advances, current limitations, and future directions.Food Sci Anim Resour2026https://conductscience.org/library/papers/42828647PubMed
42809711Microbial-derived exerkines as a model of drug discovery.Am J Physiol Cell Physiol2026https://conductscience.org/library/papers/42809711PubMed
42807701Therapeutic advances in spinal muscular atrophy: a review of clinical, safety, and economic considerations.Front Pharmacol2026https://conductscience.org/library/papers/42807701PubMed
42737573From Molecular Pathways to Artificial Intelligence: Advancing the Understanding and Management of Osteosarcopenia.Int J Mol Sci2026https://conductscience.org/library/papers/42737573PubMed
42658329Emerging Myostatin and Metabolic Hormone Pathway Modulators in Cardiometabolic Disease: Mechanisms, Evidence, and Therapeutic Potential.J Cardiovasc Transl Res2026https://conductscience.org/library/papers/42658329PubMed
42651699For Weight Loss: Why Do GLP-1 Agonists Work, and How Can We Make Them Work Better?Biology (Basel)2026https://conductscience.org/library/papers/42651699PubMed
42647268Age-Dependent Effect of Myostatin Blockade in the mdx Mouse Model of Duchenne Muscular Dystrophy (DMD).Muscles2026https://conductscience.org/library/papers/42647268PubMed
42589582Pre-Dialysis Serum Myostatin Concentration Is Independently Associated with Intradialytic Muscle Cramps in Hemodialysis Patients.Int J Mol Sci2026https://conductscience.org/library/papers/42589582PubMed
42505041Sarcopenia, cachexia and frailty in older cats: Mechanisms, assessment and therapeutic considerations.J Feline Med Surg2026https://conductscience.org/library/papers/42505041PubMed
42354079Effects of Ferulic Acid on Meat Quality, Carcass Traits, Muscle Fiber Types, and Muscle Development in Shaziling Pigs.Foods2026https://conductscience.org/library/papers/42354079PubMed
42310398Ten years of disease-modifying therapy in spinal muscular atrophy: lessons learned and future directions.Nat Rev Neurol2026https://conductscience.org/library/papers/42310398PubMed
42277171A tri-target in silico analysis of Testolift: a nutraceutical formulation targeting aromatase, myostatin, and prolyl hydroxylase-2 in testosterone regulation and muscle performance.Sci Rep2026https://conductscience.org/library/papers/42277171PubMed
42124032Sarcopenia in Chronic Heart Failure: Pathophysiology, Clinical Consequences, and Emerging Multimodal Therapeutic Strategies.Nutrients2026https://conductscience.org/library/papers/42124032PubMed
42016713Protective effects of irisin in sarcopenia: a promising treatment.J Orthop Translat2026https://conductscience.org/library/papers/42016713PubMed
41888949The effects of resistance training on myostatin in older adults with frailty and/or sarcopenia: a systematic review and meta analysis.BMC Sports Sci Med Rehabil2026https://conductscience.org/library/papers/41888949PubMed
41836288Exerkine-loaded exosomes in muscle aging: a nexus of exercise, regeneration, and crosstalk.Front Cell Dev Biol2026https://conductscience.org/library/papers/41836288PubMed
41724986The role of CXCL10 in high-fat diet-induced skeletal muscle inflammation and atrophy.J Diabetes Investig2026https://conductscience.org/library/papers/41724986PubMed

See all 47 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MSTN2660PubTator's text mininghttps://conductscience.org/library/genes/2660

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39340593

GET https://conductscience.org/api/papers/v1/39340593/references?page=2